Evogene Ltd.

Foreign Filer Report • May 28, 2019

_________ false

����� ��"�	2 380
EVOGENE LTD
Corporation no: 512838723	10571
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	28/05/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-051880	Time of broadcast: 13:36 13:12:26

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

	Delay the publication of a report	28/05/2019	14:00

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPress release: Evogene Reports First Quarter of 2019 Financial Results

1Q2019_financial_results_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 30/04/2019
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: ofer.haviv@evogene.com   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: sassi.masliah@evogene.com 1